Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Thomas, M.K., et al
In the pivotal SURPASS clinical trials evaluating tirzepatide for type 2 diabetes, and the SURMOUNT trials for weight management, sweating or hyperhidrosis was not reported among the adverse events occurring with notable frequency
Many people report no immediate effects at all, especially at lower doses
Strong initial sales of the Wegovy pill will set the tone for the success of the drug in 2026 and beyond, especially in light of an anticipated orforglipron approval in April
US$ 25.10
US$ 28.93
US$ 24.26
US$ 27.48
US$ 28.59
US$ 20.78
US$ 20.42
